BSE: DCAL - Dishman Carbogen Amcis Limited

Yield per half year: +54.81%
Sector: Healthcare

Dishman Carbogen Amcis Limited

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
1/10
164.23 56.11 192.69% 61.8 +165.74%
P/S 1.35 17.79 -92.43%
P/BV 0.0063 8.08 -99.92%
P/FCF 26.93 -381.8 -107.05%
Ev/Ebitda 11.59 4.22 174.96%
Ev/S 66.35 16.49 302.41%
Ev/FCF 2150.07 -240.24 -994.98%
E/P -0.0706 0.0159 -543.58%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
4/10
12.92 -18.77 -168.83% 19.9 -35.05%
ROE -0.054 3.69 -101.46%
ROA -0.0317 3.44 -100.92%
ROIC 0 11.26 -100%
ROS -5.87 -47.96 -87.76%
ROCE 2.61 5.09 -48.69%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
0/10
629.98 24.38 2484.38% 254.82 +147.23%
Nеt Debt/Ebitda 545.29 21.3 2460.17%
Debt/Ratio 0.205 0.126 62.78%
Debt/Equity 106.82 4.64 2204.22%
Debt/Net Income -1280.16 -49.02 2511.51%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.6496 -100% 0.4728 -100%
Number of years of dividend growth 0 0.92 -100%
DSI 0.7857 0.8171 -3.85%
Average dividend growth -32.22 1.6 -2115.53%
Average percentage for 5 years 0.4728 0.8856 -46.61%
Average percentage for payments 4.68 22.22 -78.92%
Difference from average difference in sector -0.6496

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
4/10
28 72.87 -61.58%
Growth impulse Ebitda in 5 years -47.25 72.97 -164.75%
Growth impulse Net Income in 5 years -185.11 159.06 -216.38%
Growth impulse FCF in 5 years -54.29 85.7 -163.35%
Growth impulse EPS in 5 years -187.53 104.61 -279.27%
IP Score
2.26/10

Similar companies

Shilpa Medicare Limited

Sequent Scientific Limited

Sun Pharma Advanced Research Company Limited

Hester Biosciences Limited

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription